Aurinia Pharmaceuticals Inc.AUPHNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
5.45
↓ 99% below average
Average (9y)
706.92
Historical baseline
Range
High:4964.30
Low:3.93
CAGR
-36.3%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 5.45 | -28.5% |
| 2023 | 7.61 | +93.7% |
| 2022 | 3.93 | -93.4% |
| 2021 | 59.98 | +118.7% |
| 2020 | 27.43 | -99.4% |
| 2019 | 4964.30 | +399.4% |
| 2018 | 994.05 | +101.3% |
| 2017 | 493.87 | +148.0% |
| 2016 | 199.13 | -36.5% |
| 2015 | 313.47 | - |